A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain
Status:
Not yet recruiting
Trial end date:
2023-08-16
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess whether LY3857210 is safe and efficacious in
relieving chronic low back pain (CLBP). This trial is part of the chronic pain master
protocol (H0P-MC-CPMP) which is a protocol to accelerate the development of new treatments
for chronic pain.